Cleared Traditional

K920590 - OHMEDA MODEL 5250 RGM MONITOR

K920590 is the FDA 510(k) clearance for OHMEDA MODEL 5250 RGM MONITOR by Ohmeda Medical. It is a Class 2 Anesthesiology device (product code CCK) cleared through the Traditional 510(k) pathway after a 203-day FDA review.

K920590 · Ohmeda Medical · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 1992
Decision
203d
Days
Class 2
Risk

K920590 is an FDA 510(k) clearance for the OHMEDA MODEL 5250 RGM MONITOR. Classified as Analyzer, Gas, Carbon-dioxide, Gaseous-phase (product code CCK), Class II - Special Controls.

Submitted by Ohmeda Medical (Louisville, US). The FDA issued a Cleared decision on August 31, 1992 after a review of 203 days - an extended review cycle.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.1400 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Anesthesiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Ohmeda Medical devices

Submission Details

510(k) Number K920590 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 10, 1992
Decision Date August 31, 1992
Days to Decision 203 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
63d slower than avg
Panel avg: 140d · This submission: 203d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code CCK Analyzer, Gas, Carbon-dioxide, Gaseous-phase
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.1400
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - CCK Analyzer, Gas, Carbon-dioxide, Gaseous-phase

All 124
Devices cleared under the same product code (CCK) and FDA review panel - the closest regulatory comparables to K920590.
VITALERT 3000 MONITORING SYSTEM
K913995 · Draeger Medical, Inc. · Nov 1992
DATASCOPE PASSPORT MONITOR WITH CO2
K921526 · Datascope Corp. · Oct 1992
RASCAL II
K920622 · Ohmeda Medical · Oct 1992
GAS SAMPLING INTERFACES
K914337 · Vital Signs, Inc. · Mar 1992
OHMEDA MODEL 4700 OXICAP
K911193 · Ohmeda Medical · Aug 1991
SERIES 7000 CARBON DIOXIDE MODULE
K904789 · Marquette Electronics, Inc. · May 1991